Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.475
Bid: 1.45
Ask: 1.50
Change: -0.025 (-1.67%)
Spread: 0.05 (3.448%)
Open: 1.50
High: 1.50
Low: 1.475
Prev. Close: 1.50
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Tribal shares drop on NTU contract termination

Mon, 20th Mar 2023 09:37

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Directa Plus PLC, up 4.8% at 87.00 pence, 12-month range 66.25p - 135.00p. The London-based graphene product maker says one of its graphene technologies was awarded a European patent. The company's G+ graphene technology is granted an Italian patent for air filtering applications. These include automotive applications, as well as heating ventilation and air conditioning. Its intellectual portfolio now is comprised of 22 patent families, with 81 granted patents, and a further 36 pending.

----------

Genedrive PLC, up 1.7% at 43.72 pence, 12-month range 8.00p - 48.86p. The Manchester-based molecular diagnostics company announces that that its MT-RNR1 ID kit is in process for roll out at two further hospital sites in the Greater Manchester. Genedrive's MT-RNR1 ID kit is a commercial point-of-care genetic test that helps to avoid irreversible lifelong hearing loss in specific infants exposed to aminoglycosides antibiotics by detecting a gene variant that can cause deafness, allowing for alternative antibiotics to be prescribed.

----------

AIM - LOSERS

----------

Tribal Group PLC, down 12% at 43.85 pence, 12-month range 37.00p - 96.00p. The Bristol-based educational software and services provider reports that Singapore's Nanyang Technological University has decided to terminate its contract with the company and has also reserved rights to claim damages. Tribal says it rejects NTU's right to terminate and is considering its options regarding the next appropriate steps. Consequently, the company revises the publication date of its annual results to March 24 to allow it time to consider the impact of the contract termination, particularly the accounting treatment of a GBP4.5 million onerous contract provision contained within previous expectations. Tribal has an eight-year contract with NTU for the delivery of Tribal's cloud-based SITS:Vision Student Management System and its Tribal Edge solutions. The contract was originally announced back in April 2021. In February, the company said significant delays in its Singapore contract hurt its overall trading in 2022.

----------

Jubilee Metals Group PLC, down 5.8% at 7.45 pence, 12-month range 7.30p - 17.50p. The London-based metal processing company says interim profit more than halved as the metal processing company grappled with power outages in South Africa and poor infrastructure in Zambia. Reports a 54% decline in pretax profit to GBP4.3 million for the six months that ended December 31 from GBP9.3 million a year earlier. Revenue dips to GBP63.1 million from GBP63.3 million. Platinum group metals operations record 18,208 ounces, all from own operations, down from 20,316 ounces. Records copper production of 1,149 tonnes compared to 1,314 tonnes and below expectation as a consequence of the delayed ramp-up of the Roan concentrator, mainly due to power and water disruptions in Zambia.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

Read more
3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Read more
3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

Read more
9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

Read more
28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

Read more
28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Read more
15 Jan 2019 12:44

Genedrive Interim Revenue Rises On US And UK Government Contracts

LONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end

Read more
15 Jan 2019 10:17

Genedrive makes progress with HCV kit in first half

(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.

Read more
10 Dec 2018 16:23

BGF Investment Management Now Owns 12.8% Stake In Genedrive (ALLISS)

LONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,

Read more
29 Nov 2018 13:56

Genedrive To Participate In Study For Use Of HCV Assay In Pharmacies

LONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus

Read more
29 Nov 2018 11:49

Genedrive to participate in three-country HCV therapy study

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Thursday that it will participate in an international multicentre trial, designed to assess the impact of outreach HCV diagnostics and therapy in a pharmacy setting when compared conventional treatment pathways.

Read more
22 Aug 2018 11:17

Genedrive Appoints Chris Yates As Non-Executive Director

LONDON (Alliance News) - Diagnostics company Genedrive PLC said Wednesday it appointed Chris Yates as non-executive director with immediate effect.Yates has been Chief Executive Officer of

Read more
8 Aug 2018 12:05

Genedrive Partners With FIND To Evaluate Its Hepatitis C Virus Kit

LONDON (Alliance News) - Genedrive PLC said Wednesday it partnered with the Foundation for Innovation of New Diagnostics, or FIND, which will evaluate its hepatitis C virus kit.The kit is a

Read more
20 Jun 2018 09:57

Genedrive Given Grant For NHS Point-Of-Care Test Development

LONDON (Alliance News) - Genedrive PLC's said Wednesday it was awarded a multi-partner grant to develop a pharmacogenetic test to fight antibiotic-related hearing loss in newborn molecular was

Read more
14 May 2018 18:07

Genedrive To Sell Two Divisions For Up To GBP1.9 Million In Cash

LONDON (Alliance News) - Genedrive PLC said Monday it proposed the disposal of the its contract research and pharmacogenomics divisions for up to GBP1.9 million in cash to biotechnology company 2

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.